• $45.7M
    Market Cap
  • -17.97%
    1-Year Change
  • Biotechnology
    Industry

Key Performance

More
  • Earnings Score: N/A
  • Momentum Score: 30
  • True Yield: N/A
  • Financial Health Score: N/A
TradeSmith Loading

Latest Research & News

No data found

No data found

Peers

Statistics

More
Day Range
$0.05
$0.06
$0.06
1-Year Range
$0.04
$0.09
$0.06
Latest Close$0.06
Change
+$0.003 (+5.30%)
Volume41,500
Market Cap$45.7M
Shares Outstanding419.5M
P/E (TTM)-14.34
Diluted EPS (TTM)-$0.008
Enterprise Value$54.5M

Information as of 09/11/2026

Company Profile

PROVECTUS BIOPHARMS
$45.7M
Market Cap
-$3.2M
Net Income
Sector: Healthcare
Industry: Biotechnology

PROVECTUS BIOPHARMS

Key Executives

  • Dominic Rodrigues
  • Edward V. Pershing
  • Eric A. Wachter
  • Heather Raines

Current Ownership Distribution

  • Other395.6M (94.12%)
  • Insiders20.4M (4.86%)
  • Institutions4.3M (1.02%)
  • Mutual Funds0 (0.00%)